New York Assembly Bill 500: Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.

New York · 2025-2026 session

What it does

Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.

Latest action

referred to health (2026-01-07)

See how A 500 affects you on CapitolKey

Browse more bills · CapitolKey home